Home › Products › Oncology › Capbrusam 100mg Capsule

Capbrusam 100mg Capsule

Salt Composition: ACALABRUTINIB

₹7266.00₹14531.00

Inclusive of all taxes

Capbrusam 100mg Capsule

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Capbrusam 100mg Capsule is an anticancer medicine containing the active constituent Acalabrutinib. It belongs to a class of drugs called Bruton's tyrosine kinase (BTK) inhibitors. It is used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukaemia (CLL), and small lymphocytic lymphoma (SLL). MCL, CLL, and SLL are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs and the type of lymphocytes affected. Before taking this medicine, inform your doctor if you have had recent surgery, bleeding problems, heart rhythm problems, infection, pregnancy, or breastfeeding. It is not recommended for children and adolescents less than 18 years old. This medicine can increase the risk of bleeding. Patients with Capbrusam 100mg Capsule should be monitored for signs of bleeding and should avoid taking other medications that can increase the risk of bleeding, such as blood thinners.

Uses

The Capbrusam 100 mg uses in the treatment of Chronic lymphocytic leukemia Small lymphocytic lymphoma Mantle cell lymphoma

Side Effects

Capbrusam 100mg side effects, although not everyone will experience them. Serious: Bleeding problems (bruising or bleeding) Infections (pneumonia and sepsis) High blood pressure Heart problems (irregular heartbeat and chest pain) Kidney failure Common: Headache Diarrhea Nausea Fatigue Muscle and joint pain Bruising or bleeding easily Upper respiratory tract infection Rash or itching

References

  1. AstraZeneca, Electronica medicines compendium (EMC), [Revised on Dec 2020], [ Accessed on 5th May 2023], https://www.medicines.org.uk/emc/files/pil.11917.pdf
  2. AstraZeneca, US Food and Drug Administration, [ Revised on Oct 2017], [ Accessed on 5th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/210259s000lbl.pdf
  3. John C Byrd et al; Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results; Blood; Published on April 2020; [Accessed on 5th May 2023]; https://pubmed.ncbi.nlm.nih.gov/31876911/

Safety Advice

Pregnancy: Unsafe Capbrusam 100mg Capsule is not safe during pregnancy. It can harm the developing fetus, so pregnancy should be avoided while taking this medicine.

Lungs: Consult Your Doctor If you have a lung disease or lung cancer and are considering treatment with Capbrusam 100mg Capsule, it is important to discuss this medication's potential benefits and risks with your healthcare provider.

Breastfeeding: Consult Your Doctor It is unknown whether Capbrusam 100mg Capsule is excreted into human breast milk, so breastfeeding women should consult a doctor before taking it.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS